AU5522399A - Pharmaceutical composition containing an angiotensin ii AT1 receptor antagonist and an antiplatelet agent - Google Patents

Pharmaceutical composition containing an angiotensin ii AT1 receptor antagonist and an antiplatelet agent

Info

Publication number
AU5522399A
AU5522399A AU55223/99A AU5522399A AU5522399A AU 5522399 A AU5522399 A AU 5522399A AU 55223/99 A AU55223/99 A AU 55223/99A AU 5522399 A AU5522399 A AU 5522399A AU 5522399 A AU5522399 A AU 5522399A
Authority
AU
Australia
Prior art keywords
angiotensin
pharmaceutical composition
composition containing
receptor antagonist
antiplatelet agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55223/99A
Inventor
Catherine Cazaubon
Jean-Marc Herbert
Dino Nisato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Publication of AU5522399A publication Critical patent/AU5522399A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU55223/99A 1998-09-21 1999-09-08 Pharmaceutical composition containing an angiotensin ii AT1 receptor antagonist and an antiplatelet agent Abandoned AU5522399A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9811747 1998-09-21
FR9811747A FR2783422A1 (en) 1998-09-21 1998-09-21 Composition for reducing treating hypertension or platelet aggregation disorders, contains angiotensin II receptor antagonist and platelet anti-aggregation agent
PCT/FR1999/002128 WO2000016773A1 (en) 1998-09-21 1999-09-08 Pharmaceutical composition containing an angiotensin ii at1 receptor antagonist and an antiplatelet agent

Publications (1)

Publication Number Publication Date
AU5522399A true AU5522399A (en) 2000-04-10

Family

ID=9530649

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55223/99A Abandoned AU5522399A (en) 1998-09-21 1999-09-08 Pharmaceutical composition containing an angiotensin ii AT1 receptor antagonist and an antiplatelet agent

Country Status (3)

Country Link
AU (1) AU5522399A (en)
FR (1) FR2783422A1 (en)
WO (1) WO2000016773A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1087775B1 (en) 1998-06-17 2005-08-17 Bristol-Myers Squibb Company Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination
BR0010084A (en) * 1999-04-28 2002-01-15 Takeda Chemical Industries Ltd Pharmaceutical composition, processes to prevent, treat or inhibit the development of simple retinopathy or proliferative retinopathy, and to increase retinal potential or mammalian retinal edema, and, use of a compound
EP1867342A1 (en) * 1999-07-21 2007-12-19 Takeda Pharmaceutical Company Limited Agents for ameliorating troubles following cerebrovascular failure and inhibiting progress thereof
US20020168393A1 (en) * 2001-05-08 2002-11-14 Ryota Sugimoto Implantable medical material and implantable medical device
EP1450793A2 (en) * 2001-11-23 2004-09-01 Solvay Pharmaceuticals GmbH Hypertonia treatment during the acute phase of a cerebrovascular accident
AU2005249794A1 (en) 2004-06-04 2005-12-15 Teva Pharmaceutical Industries, Ltd. Pharmaceutical composition containing irbesartan
WO2007099555A2 (en) * 2006-02-17 2007-09-07 Alembic Limited Pharmaceutical tablet compositions containing irbesartan
AR078107A1 (en) * 2009-08-31 2011-10-12 Sanofi Aventis USE OF IRBESARTAN FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE PREVENTION OF HOSPITALIZATION BY CARDIAC INSUFFICIENCY
US8765776B2 (en) 2011-04-12 2014-07-01 Boryung Pharmaceutical Co., Ltd. Antihypertensive pharmaceutical composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1087775B1 (en) * 1998-06-17 2005-08-17 Bristol-Myers Squibb Company Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination

Also Published As

Publication number Publication date
FR2783422A1 (en) 2000-03-24
WO2000016773A1 (en) 2000-03-30

Similar Documents

Publication Publication Date Title
HUP0102658A3 (en) Pharmaceutical composition containing opioid agonist and antagonist combination
HUP0201545A3 (en) Betha2-adrenergic receptor agonists and pharmaceutical compositions containing them
AU3233400A (en) Fire suppression composition and device
HUP0203638A3 (en) Betha2-adrenergic receptor agonists and pharmaceutical compositions containing them and their use
HUP0004318A3 (en) Pharmaceutical composition comprising atorvastatin and an antihypertensive agent
HUP0302969A3 (en) Npyy5 antagonists, pharmaceutical compositions containing them and their use
AU2001296650A1 (en) Seven-transmembrane (7tm) receptors and uses thereof
AU4419300A (en) Composition containing opioid antagonists and spray dispenser
IL139865A0 (en) A liver selective glucocorticoid antagonist and pharmaceutical compositions containing the same
HUP0104657A3 (en) Imidazole compounds and pharmaceutical compositions containing them
AU5565099A (en) Pharmaceutical compositions and methods for use
HUP0002324A3 (en) Benzimidazole derivatives and pharmaceutical compositions containing them
HUP0100607A3 (en) Thrombin receptor antagonists and pharmaceutical compositions containing them
AU5901900A (en) Indole and indazole urea-peptoids as thrombin receptor antagonists
HUP0300419A3 (en) Estrogen agonist/antagonist metabolites, pharmaceutical compositions containing them and their use
HUP0203121A3 (en) Pharmaceutical composition containing substituted benzimidazoles and its use
AU5522399A (en) Pharmaceutical composition containing an angiotensin ii AT1 receptor antagonist and an antiplatelet agent
AU2792700A (en) Pharmaceutical composition containing cyclosporin
HUP0200468A3 (en) Resorcinol derivatives and pharmaceutical compositions containing them
AU2742799A (en) Voacamine as anti-malarial agent and anti-malarial agent containing voacamine
AU1392800A (en) Combination of an at1 angiotensin ii receptor antagonist and an immunosuppressant
AU2001225663A1 (en) A composition comprising a combination of receptor agonists and antagonists
HUP0103184A3 (en) Sulfonyl-biphenyl-methyl-substituted imidazole derivatives, their use and pharmaceutical compositions containing them
AU6913100A (en) Notch receptor ligands and uses thereof
AU5861900A (en) Receptor agonists and antagonists

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase